The 66th Annual General Assembly and Scientific Meeting of the Japan College of Rheumatology

Late Breaking Abstracts

Submission Period

February 1 (Tue) 2022 -  March 18 (Fri) 2022, 12:00 (JST)
  March 25 (Fri) 2022, 12:00 (JST)

Application of Late breaking abstracts is closed.
Thank you for your submission.


We will be accepting “Late Breaking Abstracts” in this meeting to provide a forum for reports on the very latest research outcomes that became available after the general abstract submission period. Please see details below. We look forward to receiving your submissions!

Eligibility for Submission

Non-Japanese Citizens who reside outside of Japan

Non-Japanese Citizens who reside in Japan

  • First authors of abstracts MUST be a JCR member.
  • Non-JCR members can submit abstracts, but must become a JCR member before the submission deadline (i.e. Friday, March 18, 2022 Friday, March 25, 2022).
    Please apply for JCR membership on the following website.
  • If a first author remains a non-JCR member after the submission deadline, the abstract is subject to retraction.
  • There is no age limit for abstract submission.

Non-Japanese Citizens who are JCR members

  • Please send your JCR membership number to the secretariat after abstract submission.
  • There is no age limit for abstract submission.

How to Submit

Late Breaking Abstracts Submission Form

  • Please download the Late Breaking Abstracts Submission Form (through the link above), fill in the required information and send it by email to the Congress Secretariat:

Abstract Requirements

  • Abstracts must be of original work and may be acceptable if containing some additional information to those presented or published anywhere prior to JCR2022.
  • Please describe drugs with general name instead of drug name.
  • Accepted late breaking abstracts to JCR2022 will be published in "Mobile App for JCR2022 Abstracts".
  • Applicants cannot submit the same abstract to both English and Japanese Submission.
    (i.e. it can be submitted ONLY through either English or Japanese)
  • Abstracts may be rejected as the result of abstract review for reasons such as: contents not well organized (e.g. Section paragraphs [Object, Methods, Results, and Conclusions] are not specified), contents seen to be not suitable for presentation in JCR2022, and so on.
  • Please refrain from including the names of co-presenters in the body of the abstract.

Abstract Structure

  • Objectives
  • Methods
  • Results
  • Conclusion


* No graphs, tables, or images can be included in abstracts.
* If the abstract contents are a case report, please clearly state the clinical significance of the study.

Abstract Length

Please keep your abstract length within the following limits.

Abstract Body 2,000 characters, including spaces and punctuation
Abstract Title No Word Limit
Number of Authors Up to 30 authors
Number of Affiliations Up to 20 institutions


* First author is considered as the presenting as well as corresponding author.
* Please do not include authors' information within abstract body. Any authors' information within abstract body may be deleted from publication.
* Though no word limit is set for "Abstract Title", "Authors" and "Affiliations", the contents of the abstract may be printed in small font size if the total letter number is too large.

List of Categories

List of Categories

List of Categories

1 Clinical: Rheumatoid Arthritis (RA)
2 Clinical: Diseases Other than RA
3 Translational research & Basic

Conflict of Interest (COI)

The first author of an abstract for the JCR annual meeting must declare any financial or personal relationships that may pose conflicts of interest upon acceptance for presentation at the annual meeting.
Please refer to the COI page for COI declaration requirements.
About COI Declaration

Other Important Points

If you wish to withdraw your abstract, please contact the Congress Secretariat via email ( by March 18 (Fri) 2022, 12:00 (JST) March 25 (Fri) 2022, 12:00 (JST).

Late Breaking Abstracts Review

All submitted abstracts will be reviewed.

Result of Abstract Review

The result of the abstract review will be announced around the end of March to your registered email address as well as on the JCR2022 website.

Notifications will be sent by email. If you do not receive the notifications, please contact the Congress Secretariat by email:


For Abstract Submission

Congress Secretariat
FAX: +81-3-3510-3702

In order to prevent the spread of the novel coronavirus infection, the secretariat (c/o Congrès Inc.) has implemented telework (remote work).
Hence, we ask that you contact us through e-mail for a while.

JCR Secretariat

Japan College of Rheumatology
TEL: +81-3-6435-9761


Copyright ® The 66th Annual General Assembly and Scientific Meeting of the Japan College of Rheumatology. All Rights Reserved.